Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy
Interleukin-2 (IL-2) immunotherapy resulted in the development of inflammatory arthritis in three male patients with metastatic cancer. Two patients developed a clinical picture consistent with rheumatoid arthritis. A third patient with a remote history of Reiter's syndrome developed a recrudes...
Gespeichert in:
| Veröffentlicht in: | The American journal of medicine 1992-06, Vol.92 (6), p.693-697 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 697 |
|---|---|
| container_issue | 6 |
| container_start_page | 693 |
| container_title | The American journal of medicine |
| container_volume | 92 |
| creator | Massarotti, Elena M. Liu, Nancy Y. Mier, James Atkins, Michael B. |
| description | Interleukin-2 (IL-2) immunotherapy resulted in the development of inflammatory arthritis in three male patients with metastatic cancer. Two patients developed a clinical picture consistent with rheumatoid arthritis. A third patient with a remote history of Reiter's syndrome developed a recrudescence of an inflammatory arthritis after treatment with IL-2. The clinical, laboratory, and histologic data on the patients and the potential pathophysiologic mechanisms are discussed. |
| doi_str_mv | 10.1016/0002-9343(92)90789-E |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_232307333</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000293439290789E</els_id><sourcerecordid>5758646</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-d9b5126dc8543f9c1ff81a82ebb2b3e3a95388cd2bb2d89c899e22dc63ce03013</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVpcF2n_6CFpeTQHDbRx2pXuhSKcZOAIZfkkovQSiOv0v1IJTnB_74yNu4tcxmG931HmgehrwRfEUzqa4wxLSWr2A9JLyVuhCxXH9CccM7LhtT0I5qfLJ_Q5xif84glr2doRmrMCadz9LTswjR6U_jR9XoYdJrCrtAhdcEnHwvtEoQiBdBpgDEVbz51Rec3XWmnCDmV5R62f_xY0sJNoRh07zejHs3uHJ053Uf4cuwL9Ph79bC8Ldf3N3fLX-vSVISl0sqWE1pbI3jFnDTEOUG0oNC2tGXAtORMCGNpnq2QRkgJlFpTMwOYYcIW6Pth70uY_m4hJvU8bcOYn1SUUYYblmuBqoPJhCnGAE69BD_osFMEqz1OtWel9qyUzH2PU61y7Ntx97YdwP4PHfhl_eKo62h070I-3MeTjbOm4aLKtp8HG2QOrx6CisbDaMD6ACYpO_n3__EPiEeRrQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232307333</pqid></control><display><type>article</type><title>Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Massarotti, Elena M. ; Liu, Nancy Y. ; Mier, James ; Atkins, Michael B.</creator><creatorcontrib>Massarotti, Elena M. ; Liu, Nancy Y. ; Mier, James ; Atkins, Michael B.</creatorcontrib><description>Interleukin-2 (IL-2) immunotherapy resulted in the development of inflammatory arthritis in three male patients with metastatic cancer. Two patients developed a clinical picture consistent with rheumatoid arthritis. A third patient with a remote history of Reiter's syndrome developed a recrudescence of an inflammatory arthritis after treatment with IL-2. The clinical, laboratory, and histologic data on the patients and the potential pathophysiologic mechanisms are discussed.</description><identifier>ISSN: 0002-9343</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/0002-9343(92)90789-E</identifier><identifier>PMID: 1605152</identifier><identifier>CODEN: AJMEAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Antibodies, Antinuclear - blood ; Arthritis ; Arthritis - blood ; Arthritis - chemically induced ; Arthritis - immunology ; Arthritis, Reactive - complications ; Biological and medical sciences ; Biopsy ; Cancer ; Drug therapy ; Drug toxicity and drugs side effects treatment ; Histocompatibility Testing ; Humans ; Interleukin-2 - administration & dosage ; Interleukin-2 - adverse effects ; Male ; Medical research ; Medical sciences ; Middle Aged ; Miscellaneous (drug allergy, mutagens, teratogens...) ; Neoplasms - physiopathology ; Neoplasms - therapy ; Pharmacology. Drug treatments ; Phenotype ; Remission Induction ; Rheumatoid Factor - blood ; Synovial Fluid - chemistry ; Synovial Membrane - pathology</subject><ispartof>The American journal of medicine, 1992-06, Vol.92 (6), p.693-697</ispartof><rights>1992</rights><rights>1992 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Jun 1992</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-d9b5126dc8543f9c1ff81a82ebb2b3e3a95388cd2bb2d89c899e22dc63ce03013</citedby><cites>FETCH-LOGICAL-c413t-d9b5126dc8543f9c1ff81a82ebb2b3e3a95388cd2bb2d89c899e22dc63ce03013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0002-9343(92)90789-E$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5377584$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1605152$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Massarotti, Elena M.</creatorcontrib><creatorcontrib>Liu, Nancy Y.</creatorcontrib><creatorcontrib>Mier, James</creatorcontrib><creatorcontrib>Atkins, Michael B.</creatorcontrib><title>Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Interleukin-2 (IL-2) immunotherapy resulted in the development of inflammatory arthritis in three male patients with metastatic cancer. Two patients developed a clinical picture consistent with rheumatoid arthritis. A third patient with a remote history of Reiter's syndrome developed a recrudescence of an inflammatory arthritis after treatment with IL-2. The clinical, laboratory, and histologic data on the patients and the potential pathophysiologic mechanisms are discussed.</description><subject>Adult</subject><subject>Antibodies, Antinuclear - blood</subject><subject>Arthritis</subject><subject>Arthritis - blood</subject><subject>Arthritis - chemically induced</subject><subject>Arthritis - immunology</subject><subject>Arthritis, Reactive - complications</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Cancer</subject><subject>Drug therapy</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Histocompatibility Testing</subject><subject>Humans</subject><subject>Interleukin-2 - administration & dosage</subject><subject>Interleukin-2 - adverse effects</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>Neoplasms - physiopathology</subject><subject>Neoplasms - therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Remission Induction</subject><subject>Rheumatoid Factor - blood</subject><subject>Synovial Fluid - chemistry</subject><subject>Synovial Membrane - pathology</subject><issn>0002-9343</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1rGzEQhkVpcF2n_6CFpeTQHDbRx2pXuhSKcZOAIZfkkovQSiOv0v1IJTnB_74yNu4tcxmG931HmgehrwRfEUzqa4wxLSWr2A9JLyVuhCxXH9CccM7LhtT0I5qfLJ_Q5xif84glr2doRmrMCadz9LTswjR6U_jR9XoYdJrCrtAhdcEnHwvtEoQiBdBpgDEVbz51Rec3XWmnCDmV5R62f_xY0sJNoRh07zejHs3uHJ053Uf4cuwL9Ph79bC8Ldf3N3fLX-vSVISl0sqWE1pbI3jFnDTEOUG0oNC2tGXAtORMCGNpnq2QRkgJlFpTMwOYYcIW6Pth70uY_m4hJvU8bcOYn1SUUYYblmuBqoPJhCnGAE69BD_osFMEqz1OtWel9qyUzH2PU61y7Ntx97YdwP4PHfhl_eKo62h070I-3MeTjbOm4aLKtp8HG2QOrx6CisbDaMD6ACYpO_n3__EPiEeRrQ</recordid><startdate>19920601</startdate><enddate>19920601</enddate><creator>Massarotti, Elena M.</creator><creator>Liu, Nancy Y.</creator><creator>Mier, James</creator><creator>Atkins, Michael B.</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Sequoia S.A</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>19920601</creationdate><title>Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy</title><author>Massarotti, Elena M. ; Liu, Nancy Y. ; Mier, James ; Atkins, Michael B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-d9b5126dc8543f9c1ff81a82ebb2b3e3a95388cd2bb2d89c899e22dc63ce03013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adult</topic><topic>Antibodies, Antinuclear - blood</topic><topic>Arthritis</topic><topic>Arthritis - blood</topic><topic>Arthritis - chemically induced</topic><topic>Arthritis - immunology</topic><topic>Arthritis, Reactive - complications</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Cancer</topic><topic>Drug therapy</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Histocompatibility Testing</topic><topic>Humans</topic><topic>Interleukin-2 - administration & dosage</topic><topic>Interleukin-2 - adverse effects</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>Neoplasms - physiopathology</topic><topic>Neoplasms - therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Remission Induction</topic><topic>Rheumatoid Factor - blood</topic><topic>Synovial Fluid - chemistry</topic><topic>Synovial Membrane - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Massarotti, Elena M.</creatorcontrib><creatorcontrib>Liu, Nancy Y.</creatorcontrib><creatorcontrib>Mier, James</creatorcontrib><creatorcontrib>Atkins, Michael B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Massarotti, Elena M.</au><au>Liu, Nancy Y.</au><au>Mier, James</au><au>Atkins, Michael B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>1992-06-01</date><risdate>1992</risdate><volume>92</volume><issue>6</issue><spage>693</spage><epage>697</epage><pages>693-697</pages><issn>0002-9343</issn><eissn>1555-7162</eissn><coden>AJMEAZ</coden><abstract>Interleukin-2 (IL-2) immunotherapy resulted in the development of inflammatory arthritis in three male patients with metastatic cancer. Two patients developed a clinical picture consistent with rheumatoid arthritis. A third patient with a remote history of Reiter's syndrome developed a recrudescence of an inflammatory arthritis after treatment with IL-2. The clinical, laboratory, and histologic data on the patients and the potential pathophysiologic mechanisms are discussed.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>1605152</pmid><doi>10.1016/0002-9343(92)90789-E</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-9343 |
| ispartof | The American journal of medicine, 1992-06, Vol.92 (6), p.693-697 |
| issn | 0002-9343 1555-7162 |
| language | eng |
| recordid | cdi_proquest_journals_232307333 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adult Antibodies, Antinuclear - blood Arthritis Arthritis - blood Arthritis - chemically induced Arthritis - immunology Arthritis, Reactive - complications Biological and medical sciences Biopsy Cancer Drug therapy Drug toxicity and drugs side effects treatment Histocompatibility Testing Humans Interleukin-2 - administration & dosage Interleukin-2 - adverse effects Male Medical research Medical sciences Middle Aged Miscellaneous (drug allergy, mutagens, teratogens...) Neoplasms - physiopathology Neoplasms - therapy Pharmacology. Drug treatments Phenotype Remission Induction Rheumatoid Factor - blood Synovial Fluid - chemistry Synovial Membrane - pathology |
| title | Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A28%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20inflammatory%20arthritis%20after%20treatment%20with%20high-dose%20interleukin-2%20for%20malignancy&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Massarotti,%20Elena%20M.&rft.date=1992-06-01&rft.volume=92&rft.issue=6&rft.spage=693&rft.epage=697&rft.pages=693-697&rft.issn=0002-9343&rft.eissn=1555-7162&rft.coden=AJMEAZ&rft_id=info:doi/10.1016/0002-9343(92)90789-E&rft_dat=%3Cproquest_cross%3E5758646%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=232307333&rft_id=info:pmid/1605152&rft_els_id=000293439290789E&rfr_iscdi=true |